Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „ADCETRIS“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · For safety information of chemotherapy agents given in combination with ADCETRIS (doxorubicin, vinblastine and
Eintrag öffnenAdcetris · 4.8 · For safety information of chemotherapy agents given in combination with ADCETRIS (etoposide, cyclophosphamide,
Eintrag öffnenAdcetris · 4.8 · IRRs, such as headache, rash, back pain, vomiting, chills, nausea, dyspnoea, pruritus and cough were reported
Eintrag öffnenAdcetris · 4.8 · Immunogenicity
Eintrag öffnenAdcetris · 4.8 · In clinical trials (C25003 [ADCETRIS + AVD] and SGN35-014 [ADCETRIS + CHP]), IRRs, such as headache, rash, bac
Eintrag öffnenAdcetris · 4.8 · In clinical trials treatment emergent neuropathy occurred in 57% of the population, peripheral motor neuropath
Eintrag öffnenAdcetris · 4.8 · In clinical trials, neutropenia led to dose delays in 13% of patients. Grade 3 neutropenia was reported in 13%
Eintrag öffnenAdcetris · 4.8 · In clinical trials, patients were periodically tested for antibodies to brentuximab vedotin using a sensitive
Eintrag öffnenAdcetris · 4.8 · In clinical trials, serious infections and opportunistic infections occurred in 10% of patients, sepsis or sep
Eintrag öffnenAdcetris · 4.8 · In older patients from clinical trials C25003 (ADCETRIS + AVD) and SGN35-014 (ADCETRIS + CHP) (≥ 60 years of a
Eintrag öffnenAdcetris · 4.8 · In patients receiving ADCETRIS combination therapy, serious adverse reactions occurred in 34% of patients. Ser
Eintrag öffnenAdcetris · 4.8 · In patients with relapsed or refractory HL or sALCL who were retreated with ADCETRIS (SGN35-006), the majority
Eintrag öffnenAdcetris · 4.8 · In the HD21 study, 747 patients received BrECADD, and 741 patients received eBEACOPP (escalated bleomycin [B],
Eintrag öffnenAdcetris · 4.8 · In the clinical trial (HD21 [BrECADD]) of ADCETRIS as combination therapy, treatment emergent peripheral senso
Eintrag öffnenAdcetris · 4.8 · In the clinical trial HD21 (BrECADD) of ADCETRIS as combination therapy, neutropenia led to treatment delays i
Eintrag öffnenAdcetris · 4.8 · In the clinical trial of ADCETRIS as combination therapy with AVD, treatment emergent neuropathy occurred in 6
Eintrag öffnenAdcetris · 4.8 · In the clinical trial of ADCETRIS as combination therapy with CHP, treatment emergent neuropathy occurred in 5
Eintrag öffnenAdcetris · 4.8 · In the clinical trials (C25003 [ADCETRIS + AVD] and SGN35-014 [ADCETRIS + CHP]) of ADCETRIS as combination the
Eintrag öffnenAdcetris · 4.8 · In the clinical trials (HD21 [BrECADD]) of ADCETRIS as combination therapy, serious infections and infestation
Eintrag öffnenAdcetris · 4.8 · In the clinical trials C25003 (ADCETRIS + AVD) and SGN35-014 (ADCETRIS + CHP) of ADCETRIS as combination thera
Eintrag öffnen